Suresh B. Lakshminarayana
Novartis (Switzerland)(CH)Novant Health(US)Novartis (United States)(US)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Malaria Research and Control, Mosquito-borne diseases and control, Trypanosoma species research and implications, Cancer therapeutics and mechanisms
Most-Cited Works
- → Spiroindolones, a Potent Compound Class for the Treatment of Malaria(2010)1,193 cited
- → Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of Malaria(2010)420 cited
- → An adenosine nucleoside inhibitor of dengue virus(2009)393 cited
- → A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy(2010)304 cited
- → A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis(2017)195 cited
- → Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents(2014)151 cited
- → Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis